BGM Group Ltd. (NASDAQ:BGM) Short Interest Update

BGM Group Ltd. (NASDAQ:BGM) saw a significant drop in short interest in February. As of February 27th, there was short interest totaling 65,241 shares, a drop of 13.0% from the February 12th total of 74,988 shares. Based on an average daily volume of 24,801 shares, the days-to-cover ratio is presently 2.6 days. Currently, 0.2% of the company’s stock are sold short. Currently, 0.2% of the company’s stock are sold short. Based on an average daily volume of 24,801 shares, the days-to-cover ratio is presently 2.6 days.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of BGM Group in a report on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, BGM Group has an average rating of “Sell”.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in BGM. Geode Capital Management LLC purchased a new stake in BGM Group in the second quarter valued at about $412,000. Marshall Wace LLP acquired a new stake in BGM Group in the second quarter worth about $218,000. Finally, Mariner LLC purchased a new stake in shares of BGM Group during the third quarter worth about $267,000.

BGM Group Stock Performance

Shares of BGM opened at $0.93 on Tuesday. The company has a 50 day moving average of $2.15 and a two-hundred day moving average of $5.91. BGM Group has a twelve month low of $0.92 and a twelve month high of $17.17.

About BGM Group

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.